
    
      This trial will be conducted in two phases: a feasibility then a phase II trial. Once
      feasibility and safety are established in the first 12 pts. the phase II study will begin.
      Proton therapy at standard doses is not known to improve clinical outcome but will likely
      reduce fatigue and toxicity.
    
  